data_1i2u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i2u _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.514 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.48 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 120.664 0.269 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.635 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.482 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.469 ' NE ' ' HG3' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' CG ' HG22 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 120.505 0.193 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.605 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 43.8 m-80 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.408 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.487 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.487 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.2 t . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.49 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.595 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt . . . . . 0 N--CA 1.508 2.442 0 CA-C-O 120.525 0.202 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.471 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.424 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.55 ' NH2' ' O ' ' A' ' 4' ' ' ILE . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.424 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.531 ' HZ3' ' CB ' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.49 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 30.3 m-80 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CD1' HG21 ' A' ' 15' ' ' THR . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE2' ' CE2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.654 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.467 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.533 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.488 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.638 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? . . . . . 0 N--CA 1.51 2.554 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.488 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HZ2' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.665 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.418 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.539 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 119.173 -0.441 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.487 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.668 ' CG ' HG22 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.487 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.635 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.403 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.667 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.406 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.639 HG23 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.787 -0.079 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 6' ' ' SER . 0.1 OUTLIER -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.678 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.563 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.8 0.333 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.481 HD12 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.48 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.477 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.484 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t . . . . . 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.48 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m120 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.4 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.427 0.156 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.461 ' N ' HD11 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.45 ' CG ' HG23 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 HG23 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 39' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 1.1 m120 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.663 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.457 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CG ' HG23 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.597 HG23 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.461 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HZ1' ' C ' ' A' ' 44' ' ' THR . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.489 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.461 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.623 ' C ' ' HZ1' ' A' ' 28' ' ' LYS . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.663 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -150.05 145.85 26.62 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.225 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.514 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.48 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t -63.34 167.64 5.14 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.61 57.0 0.06 OUTLIER Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.191 -1.48 . . . . 0.0 111.611 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.7 m -149.49 -154.04 0.53 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -93.21 141.52 28.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.68 28.66 0.35 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 123.196 0.31 . . . . 0.0 111.512 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.635 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.97 127.16 56.15 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.482 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' NE ' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.469 ' NE ' ' HG3' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' CG ' HG22 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t -83.49 167.13 17.7 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.542 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 m -155.56 -153.74 0.46 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -91.63 138.63 31.41 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.55 29.67 0.43 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 123.476 0.485 . . . . 0.0 111.009 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.408 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 43.8 m-80 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.408 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -94.47 166.14 12.2 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.206 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.526 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.487 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.595 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.487 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.2 t -74.75 169.57 17.6 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.01 42.43 0.07 OUTLIER Glycine 0 N--CA 1.506 3.343 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.359 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 m -127.43 -150.29 0.44 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -93.55 138.86 31.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.81 35.25 0.49 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.668 0.605 . . . . 0.0 111.402 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.595 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -122.42 148.84 44.62 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.363 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.471 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.424 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' NH2' ' O ' ' A' ' 4' ' ' ILE . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -81.84 154.03 26.1 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.86 -99.63 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.85 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -164.7 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -66.03 129.42 39.72 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.62 -1.632 . . . . 0.0 110.129 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.91 28.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.443 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -125.72 144.85 50.44 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.701 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.531 ' HZ3' ' CB ' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t -85.15 170.05 13.27 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.19 57.55 0.07 OUTLIER Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.258 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -141.57 -151.57 0.37 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -92.44 139.8 30.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.07 31.87 0.38 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.33 0.394 . . . . 0.0 111.798 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 30.3 m-80 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -130.81 164.36 25.35 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.472 ' CD1' HG21 ' A' ' 15' ' ' THR . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE2' ' CE2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.407 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t -74.66 170.08 16.53 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.68 59.6 0.05 OUTLIER Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.377 -1.392 . . . . 0.0 111.109 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m -148.01 -154.92 0.58 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -92.64 139.78 30.21 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.88 28.58 0.37 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.344 0.402 . . . . 0.0 111.337 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.654 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.467 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.638 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.533 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.533 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.677 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.488 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t -80.84 154.38 27.14 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.85 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.824 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -165.53 -70.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.481 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -76.93 132.91 39.32 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.55 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 39.5 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.631 -1.622 . . . . 0.0 113.701 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.638 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? -120.58 143.22 48.74 Favored 'General case' 0 N--CA 1.51 2.554 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.077 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.488 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HZ2' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.587 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t -82.11 157.46 24.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.939 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.1 m -166.74 -69.97 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 118.612 1.206 . . . . 0.0 112.374 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -70.23 128.52 36.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.739 -1.584 . . . . 0.0 110.466 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 38.64 24.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.666 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.665 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.418 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.539 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt -115.25 122.73 46.87 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.194 0.452 . . . . 0.0 110.28 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.487 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.668 ' CG ' HG22 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.487 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t -75.99 165.77 24.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.27 70.54 0.05 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.266 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.2 m -156.49 -152.86 0.39 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.19 136.08 33.22 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.17 33.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.635 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.403 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.668 HG22 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -116.45 116.02 26.89 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.894 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.639 ' CG ' HG23 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -84.87 159.5 20.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' ASN . . . -55.84 -99.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.279 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 m -163.88 -70.26 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.364 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -74.35 129.65 38.19 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.618 -1.633 . . . . 0.0 110.354 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 37.37 27.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.341 -1.754 . . . . 0.0 113.137 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.667 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' GLY . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.406 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.639 HG23 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -95.34 148.52 22.35 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.787 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.464 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 6' ' ' SER . 0.1 OUTLIER -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.563 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t -82.81 168.64 16.95 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.46 55.6 0.06 OUTLIER Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.668 -1.73 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.1 m -146.44 -153.23 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -93.14 139.79 30.21 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 45.1 28.87 0.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.342 0.401 . . . . 0.0 111.77 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.678 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 1' ' ' ASP . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.563 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt -110.05 124.54 51.65 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 123.665 0.603 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t -77.0 154.41 33.53 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.14 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.093 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.3 -69.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.03 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.07 124.27 20.04 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 117.046 -1.862 . . . . 0.0 110.809 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.28 28.82 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.091 -1.868 . . . . 0.0 113.252 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.652 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -114.0 124.49 52.26 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.391 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.481 HD12 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.48 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.477 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.484 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t -72.13 169.47 16.0 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.52 56.04 0.05 OUTLIER Glycine 0 N--CA 1.5 2.949 0 C-N-CA 119.393 -1.384 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -140.63 -149.22 0.27 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -93.32 136.96 33.09 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.32 34.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.324 0.39 . . . . 0.0 111.677 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.48 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m120 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.4 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -130.22 150.44 51.47 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.946 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.461 ' N ' HD11 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.45 ' CG ' HG23 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.501 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.551 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t -84.63 156.38 21.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.31 -95.57 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.6 m -165.6 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.038 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.72 133.87 39.37 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 117.552 -1.659 . . . . 0.0 111.391 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 40.58 23.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.602 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 HG23 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -109.14 134.39 51.78 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.713 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 39' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.96 156.56 24.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -99.05 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.949 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -169.09 -72.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 118.79 1.295 . . . . 0.0 111.955 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.24 126.19 26.47 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.511 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.92 26.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.59 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 1.1 m120 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.663 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -124.64 122.95 38.96 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.147 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CG ' HG23 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t -77.68 154.35 32.22 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.27 -95.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.233 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.214 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -166.36 -74.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.094 0.947 . . . . 0.0 113.145 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -76.12 134.19 40.06 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.202 -1.399 . . . . 0.0 111.054 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.98 21.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.718 -1.583 . . . . 0.0 113.757 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.597 HG23 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' CYS . 33.0 t70 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.332 0.587 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -81.21 156.19 25.77 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.293 -1.363 . . . . 0.0 110.284 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HZ1' ' C ' ' A' ' 44' ' ' THR . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.489 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t -86.45 157.47 19.8 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.13 -98.48 0.01 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.906 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -162.74 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.397 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -74.97 133.36 41.72 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.069 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.06 24.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.354 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.461 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.623 ' C ' ' HZ1' ' A' ' 28' ' ' LYS . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -112.57 137.84 50.23 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.11 61.28 0.04 OUTLIER Glycine 0 N--CA 1.504 3.193 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.888 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 61.5 m -150.18 -151.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -91.51 137.48 32.33 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.62 30.14 0.33 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.579 0.549 . . . . 0.0 111.645 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.663 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 120.664 0.269 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.416 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.417 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ2' ' HG3' ' A' ' 28' ' ' LYS . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 120.505 0.193 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.624 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 26.6 m120 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 6' ' ' SER . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 6.2 t . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.571 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt . . . . . 0 N--CA 1.508 2.442 0 CA-C-O 120.525 0.202 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.507 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 28' ' ' LYS . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.505 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 21' ' ' GLU . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.437 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' CB ' ' HZ2' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 17.4 m120 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 54.7 t-20 -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.574 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.574 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.733 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? . . . . . 0 N--CA 1.51 2.554 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.432 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.487 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.751 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 119.173 -0.441 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 38' ' ' VAL . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.851 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 8' ' ' VAL . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 44' ' ' THR . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.851 HG21 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.787 -0.079 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 5' ' ' GLY . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.577 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.571 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.8 0.333 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.488 HD13 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t . . . . . 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.572 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 m-80 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD13 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.528 HG22 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.427 0.156 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CG ' HG21 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.541 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 40.1 t-20 -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 43' ' ' GLU . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.5 m-20 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.52 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 27' ' ' TYR . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 40' ' ' CYS . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 22' ' ' CYS . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CG ' HG21 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.713 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.688 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 5' ' ' GLY . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 4' ' ' ILE . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 38.5 t-20 -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.679 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 27' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.697 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' CYS . 7.7 p-10 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -150.05 145.85 26.62 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.225 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t -63.34 167.64 5.14 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.61 57.0 0.06 OUTLIER Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.191 -1.48 . . . . 0.0 111.611 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.7 m -149.49 -154.04 0.53 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -93.21 141.52 28.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.68 28.66 0.35 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 123.196 0.31 . . . . 0.0 111.512 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 1' ' ' ASP . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.97 127.16 56.15 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.417 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ2' ' HG3' ' A' ' 28' ' ' LYS . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t -83.49 167.13 17.7 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.542 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 m -155.56 -153.74 0.46 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -91.63 138.63 31.41 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.55 29.67 0.43 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 123.476 0.485 . . . . 0.0 111.009 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.624 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 43.8 m-80 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -94.47 166.14 12.2 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.206 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 6' ' ' SER . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 6.2 t -74.75 169.57 17.6 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.01 42.43 0.07 OUTLIER Glycine 0 N--CA 1.506 3.343 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.359 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.2 m -127.43 -150.29 0.44 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -93.55 138.86 31.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.81 35.25 0.49 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.668 0.605 . . . . 0.0 111.402 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.571 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 34' ' ' SER . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -122.42 148.84 44.62 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.363 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.507 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 28' ' ' LYS . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -81.84 154.03 26.1 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.86 -99.63 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.85 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -164.7 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -66.03 129.42 39.72 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.62 -1.632 . . . . 0.0 110.129 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.91 28.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.443 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -125.72 144.85 50.44 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.701 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.505 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.597 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 21' ' ' GLU . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' CB ' ' HZ2' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t -85.15 170.05 13.27 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.19 57.55 0.07 OUTLIER Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.258 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -141.57 -151.57 0.37 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -92.44 139.8 30.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.07 31.87 0.38 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.33 0.394 . . . . 0.0 111.798 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 17.4 m120 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 16.4 m-20 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -130.81 164.36 25.35 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t -74.66 170.08 16.53 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.68 59.6 0.05 OUTLIER Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.377 -1.392 . . . . 0.0 111.109 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m -148.01 -154.92 0.58 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -92.64 139.78 30.21 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.88 28.58 0.37 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.344 0.402 . . . . 0.0 111.337 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 54.7 t-20 -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.574 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.574 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t -80.84 154.38 27.14 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.85 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.824 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -165.53 -70.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.481 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -76.93 132.91 39.32 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.55 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 39.5 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.631 -1.622 . . . . 0.0 113.701 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.733 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? -120.58 143.22 48.74 Favored 'General case' 0 N--CA 1.51 2.554 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.077 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.432 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.487 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t -82.11 157.46 24.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.939 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.1 m -166.74 -69.97 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 118.612 1.206 . . . . 0.0 112.374 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -70.23 128.52 36.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.739 -1.584 . . . . 0.0 110.466 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 38.64 24.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.666 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.751 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt -115.25 122.73 46.87 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.194 0.452 . . . . 0.0 110.28 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 38' ' ' VAL . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.851 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t -75.99 165.77 24.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.27 70.54 0.05 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.266 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.2 m -156.49 -152.86 0.39 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.19 136.08 33.22 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.17 33.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 8' ' ' VAL . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 44' ' ' THR . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.851 HG21 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -116.45 116.02 26.89 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.894 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -84.87 159.5 20.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' ASN . . . -55.84 -99.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.279 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 m -163.88 -70.26 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.364 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -74.35 129.65 38.19 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.618 -1.633 . . . . 0.0 110.354 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 37.37 27.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.341 -1.754 . . . . 0.0 113.137 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -95.34 148.52 22.35 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.787 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 5' ' ' GLY . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.4 p30 -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t -82.81 168.64 16.95 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.46 55.6 0.06 OUTLIER Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.668 -1.73 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.1 m -146.44 -153.23 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -93.14 139.79 30.21 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 45.1 28.87 0.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.342 0.401 . . . . 0.0 111.77 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 1' ' ' ASP . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.577 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 1.1 m-20 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt -110.05 124.54 51.65 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 123.665 0.603 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.571 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t -77.0 154.41 33.53 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.14 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.093 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.3 -69.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.03 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.07 124.27 20.04 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 117.046 -1.862 . . . . 0.0 110.809 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.28 28.82 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.091 -1.868 . . . . 0.0 113.252 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 1' ' ' ASP . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -114.0 124.49 52.26 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.391 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.488 HD13 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' CD ' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t -72.13 169.47 16.0 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.52 56.04 0.05 OUTLIER Glycine 0 N--CA 1.5 2.949 0 C-N-CA 119.393 -1.384 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -140.63 -149.22 0.27 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -93.32 136.96 33.09 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.32 34.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.324 0.39 . . . . 0.0 111.677 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.572 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 m-80 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD13 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.528 HG22 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -130.22 150.44 51.47 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.946 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CG ' HG21 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.541 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t -84.63 156.38 21.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.31 -95.57 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.6 m -165.6 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.038 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.72 133.87 39.37 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 117.552 -1.659 . . . . 0.0 111.391 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 40.58 23.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.602 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -109.14 134.39 51.78 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.713 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 22' ' ' CYS . 40.1 t-20 -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 43' ' ' GLU . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.96 156.56 24.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -99.05 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.949 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -169.09 -72.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 118.79 1.295 . . . . 0.0 111.955 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.24 126.19 26.47 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.511 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.92 26.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.59 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.5 m-20 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 27' ' ' TYR . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -124.64 122.95 38.96 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.147 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 40' ' ' CYS . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 22' ' ' CYS . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CG ' HG21 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t -77.68 154.35 32.22 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.27 -95.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.233 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.214 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -166.36 -74.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.094 0.947 . . . . 0.0 113.145 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -76.12 134.19 40.06 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.202 -1.399 . . . . 0.0 111.054 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.98 21.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.718 -1.583 . . . . 0.0 113.757 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.713 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.688 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.332 0.587 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -81.21 156.19 25.77 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.293 -1.363 . . . . 0.0 110.284 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 5' ' ' GLY . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 4' ' ' ILE . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' OD1' ' HA2' ' A' ' 29' ' ' GLY . 38.5 t-20 -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t -86.45 157.47 19.8 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.13 -98.48 0.01 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.906 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -162.74 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.397 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -74.97 133.36 41.72 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.069 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.06 24.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.354 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.679 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 27' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -112.57 137.84 50.23 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.11 61.28 0.04 OUTLIER Glycine 0 N--CA 1.504 3.193 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.888 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.407 ' CB ' HG12 ' A' ' 38' ' ' VAL . 61.5 m -150.18 -151.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -91.51 137.48 32.33 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.62 30.14 0.33 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.579 0.549 . . . . 0.0 111.645 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.697 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.533 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 120.664 0.269 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.416 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.417 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ2' ' HG3' ' A' ' 28' ' ' LYS . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 120.505 0.193 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.624 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 43.8 m-80 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 6' ' ' SER . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.516 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 6.2 t . . . . . 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.28 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.571 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt . . . . . 0 N--CA 1.508 2.442 0 CA-C-O 120.525 0.202 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.507 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.444 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.483 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 110.701 -0.111 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.505 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 21' ' ' GLU . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.437 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HZ2' ' CB ' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 30.3 m-80 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt . . . . . 0 N--CA 1.505 2.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE2' ' CE2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.407 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.565 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.574 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.574 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.565 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.733 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? . . . . . 0 N--CA 1.51 2.554 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.432 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.487 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.751 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt . . . . . 0 N--CA 1.502 2.14 0 CA-C-O 119.173 -0.441 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 38' ' ' VAL . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.53 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.851 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.53 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 8' ' ' VAL . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 44' ' ' THR . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.851 HG21 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? . . . . . 0 N--CA 1.503 2.182 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.787 -0.079 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 5' ' ' GLY . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.514 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 6' ' ' SER . 0.1 OUTLIER -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t . . . . . 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.577 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt . . . . . 0 N--CA 1.504 2.262 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.421 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.571 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.8 0.333 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.488 HD13 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t . . . . . 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.572 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.484 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.431 HD22 ' CD1' ' A' ' 3' ' ' LEU . 2.6 m120 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD13 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.528 HG22 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 N--CA 1.505 2.324 0 CA-C-O 120.427 0.156 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CG ' HG21 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.541 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 43' ' ' GLU . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.496 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 1.1 m120 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.52 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 27' ' ' TYR . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 40' ' ' CYS . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 22' ' ' CYS . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.536 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CG ' HG21 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.713 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.688 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 5' ' ' GLY . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 4' ' ' ILE . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.559 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.559 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t . . . . . 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.679 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 27' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? . . . . . 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.697 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 42' ' ' CYS . 7.7 p-10 . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -150.05 145.85 26.62 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.225 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 tp -81.95 128.66 34.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.221 -0.299 . . . . 0.0 111.078 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -121.95 4.44 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.919 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.65 -177.76 43.0 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -99.46 -171.42 2.07 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.6 t -146.41 17.88 1.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.989 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.02 -23.18 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 65.32 71.83 0.43 Allowed 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.4 -30.25 0.41 Allowed Glycine 0 N--CA 1.499 2.894 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.8 24.32 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.06 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.765 0.793 . . . . 0.0 111.093 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.55 23.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.115 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.2 t80 -78.53 140.53 38.53 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.99 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.9 p -108.46 96.09 6.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.8 t -59.88 -40.09 87.52 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.003 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -110.34 70.47 0.72 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 31' ' ' HIS . 5.1 t -47.43 -45.76 25.88 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.013 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -45.83 56.19 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.473 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.43 -46.54 57.96 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.79 -48.42 74.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -52.97 -50.41 64.17 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.97 0.89 . . . . 0.0 109.723 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -58.93 -42.9 90.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -57.24 -23.63 49.39 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.4 12.27 31.87 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.21 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.37 1.27 90.32 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 9.1 m-30 -76.54 -165.5 0.52 Allowed 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 117.897 -1.521 . . . . 0.0 110.748 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -119.77 -25.71 5.83 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.17 153.69 15.16 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.493 ' HA3' ' SG ' ' A' ' 22' ' ' CYS . . . -165.91 154.37 24.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.533 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -169.63 174.06 6.02 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 122.59 -0.359 . . . . 0.0 110.482 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 9.1 t -63.34 167.64 5.14 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.61 57.0 0.06 OUTLIER Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.191 -1.48 . . . . 0.0 111.611 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.7 m -149.49 -154.04 0.53 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -93.21 141.52 28.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.68 28.66 0.35 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 123.196 0.31 . . . . 0.0 111.512 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.672 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.1 m-80 53.77 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.194 0.521 . . . . 0.0 110.492 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.55 -27.0 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -133.28 149.5 51.94 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.353 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.52 118.13 34.27 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -102.38 144.36 30.96 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.636 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 1' ' ' ASP . 3.0 t -105.49 167.24 9.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 76.4 mt-10 -109.04 46.76 0.96 Allowed 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.789 0.804 . . . . 0.0 112.843 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 112.745 -3.502 . . . . 0.0 110.123 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -112.97 127.16 56.15 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.445 0.64 . . . . 0.0 110.191 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.8 tt -84.66 120.86 26.87 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.417 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -119.61 12.46 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.536 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.96 -179.31 41.29 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.46 -169.52 1.92 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 53.2 t -148.57 19.82 1.04 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.608 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.495 HG22 HG12 ' A' ' 38' ' ' VAL . 19.2 t -85.44 -115.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.331 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -169.43 106.72 0.39 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.953 -1.092 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.82 -28.71 12.34 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.744 -1.217 . . . . 0.0 110.608 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 144.46 35.77 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.273 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.31 69.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.232 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -175.1 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.886 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.06 140.86 15.05 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.583 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.89 110.23 21.51 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.801 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 t -54.71 -36.76 65.06 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.335 1.064 . . . . 0.0 109.087 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -123.76 80.13 1.77 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.015 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 4.8 t -45.28 -62.22 1.35 Allowed 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 121.525 0.679 . . . . 0.0 111.856 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -68.23 -26.73 65.84 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.308 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.6 -50.29 65.7 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.1 tp10 -63.27 -47.97 80.12 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.43 -49.6 69.62 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.553 1.168 . . . . 0.0 109.697 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 26.1 tptp -58.89 -41.31 86.85 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.0 -26.45 60.26 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.0 mtt180 -96.46 16.63 18.1 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.05 21.05 52.05 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 44' ' ' THR . 9.5 m-30 -79.72 -169.32 1.91 Allowed 'General case' 0 N--CA 1.504 2.267 0 C-N-CA 118.578 -1.249 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ2' ' HG3' ' A' ' 28' ' ' LYS . 24.3 mttp -84.02 -64.28 1.19 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.265 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -164.77 177.13 40.44 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -160.4 153.69 24.64 Favored Glycine 0 N--CA 1.491 2.354 0 CA-C-N 118.374 1.087 . . . . 0.0 110.428 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 11.9 p-80 -167.04 176.47 6.88 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 25.3 t -83.49 167.13 17.7 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.69 66.59 0.05 OUTLIER Glycine 0 N--CA 1.498 2.77 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.542 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 m -155.56 -153.74 0.46 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -91.63 138.63 31.41 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.55 29.67 0.43 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 123.476 0.485 . . . . 0.0 111.009 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.624 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 46.0 m-20 56.88 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.589 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG12 HG22 ' A' ' 8' ' ' VAL . 11.7 m -126.86 -26.3 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HB2' ' NE1' ' A' ' 41' ' ' TRP . 43.8 m-80 -129.19 141.96 51.0 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.15 114.83 29.14 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' NE1' ' HB2' ' A' ' 39' ' ' ASN . 25.3 m95 -103.31 145.62 29.68 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.32 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 2.5 m -104.95 166.2 10.55 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.8 mp0 -83.53 -19.12 36.25 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.601 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.426 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.497 1.924 0 C-N-CA 116.7 -2.0 . . . . 0.0 109.533 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.051 0.453 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -94.47 166.14 12.2 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.206 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.1 tt -114.35 122.22 46.02 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 121.399 -0.813 . . . . 0.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -120.01 -8.52 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.177 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.07 -178.35 48.2 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.406 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -113.79 -168.44 1.35 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.419 -0.459 . . . . 0.0 110.362 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 60.9 m -131.17 35.41 3.92 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.93 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 45.3 t -117.55 92.77 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.816 -0.552 . . . . 0.0 110.987 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -46.39 92.23 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.566 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.91 -32.43 1.08 Allowed Glycine 0 N--CA 1.5 2.937 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.69 158.1 36.25 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.4 p -84.42 44.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 122.115 0.959 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 6' ' ' SER . 24.9 p30 -163.76 18.69 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.038 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 88.5 t80 -75.03 154.03 38.19 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.315 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.17 95.22 4.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.8 m -52.66 -33.95 49.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -131.89 73.23 1.52 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.492 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 11.7 t -45.44 -63.07 1.03 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.168 0.509 . . . . 0.0 112.201 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -63.47 -33.85 76.47 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.393 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.07 -54.52 36.85 Favored Glycine 0 N--CA 1.502 3.087 0 N-CA-C 107.231 -2.347 . . . . 0.0 107.231 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.73 -47.24 86.14 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' HA3' ' A' ' 30' ' ' GLY . 3.0 t -47.61 -51.06 22.6 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.902 0.858 . . . . 0.0 110.109 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -60.1 -44.35 94.9 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -58.99 -24.98 63.23 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 0.6 OUTLIER -87.98 7.05 32.94 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.257 -179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.41 9.8 85.8 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' CD2' ' HB2' ' A' ' 25' ' ' ARG . 21.7 m-85 -85.32 158.67 20.22 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 117.946 0.873 . . . . 0.0 109.408 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 44' ' ' THR . 7.7 ptmt -73.9 -26.59 60.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.65 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 173.76 156.61 13.66 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -158.6 152.97 24.13 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.519 -1.833 . . . . 0.0 108.519 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.492 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 8.5 p-80 -168.67 175.89 5.88 Favored 'General case' 0 N--CA 1.507 2.408 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 40' ' ' CYS . 6.2 t -74.75 169.57 17.6 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 117.966 -1.493 . . . . 0.0 108.045 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.01 42.43 0.07 OUTLIER Glycine 0 N--CA 1.506 3.343 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.359 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 38' ' ' VAL . 7.2 m -127.43 -150.29 0.44 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -93.55 138.86 31.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.739 -0.601 . . . . 0.0 109.524 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.81 35.25 0.49 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 123.668 0.605 . . . . 0.0 111.402 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.571 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 5.6 m120 57.59 81.85 0.14 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.724 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 34' ' ' SER . 14.8 p -122.66 -27.74 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.234 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 1.5 m120 -132.08 149.46 52.4 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.638 -0.825 . . . . 0.0 112.597 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -120.46 125.51 48.08 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 50.8 m95 -112.29 151.82 29.23 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.985 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 1.3 m -117.25 171.02 8.24 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB3' ' CG ' ' A' ' 28' ' ' LYS . 3.6 mm-40 -121.84 147.35 46.09 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.463 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' A' ' 28' ' ' LYS . 32.0 p . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 115.922 -1.989 . . . . 0.0 108.572 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -122.42 148.84 44.62 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.363 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 8.0 tt -97.94 118.23 34.06 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.302 -0.874 . . . . 0.0 110.151 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -119.64 -12.57 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.52 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 176.11 46.58 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.507 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 12.6 t -98.32 168.95 9.9 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.667 -0.902 . . . . 0.0 109.805 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 13.0 t -128.84 28.93 5.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 118.758 -1.177 . . . . 0.0 107.906 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.0 t -113.35 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.791 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -44.44 104.06 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.661 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.49 -26.53 2.41 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.29 160.17 22.97 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.597 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.39 48.31 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.957 0.884 . . . . 0.0 111.18 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 19.7 p30 -168.15 22.05 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.214 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.7 149.04 45.85 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.099 -1.041 . . . . 0.0 109.422 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.09 113.92 27.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.503 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.8 t -64.47 -52.22 59.09 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -115.89 86.45 2.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.1 t -44.8 -59.79 2.35 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.455 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.444 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -66.31 -43.18 86.95 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.953 -1.099 . . . . 0.0 111.011 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.5 -49.55 38.94 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -64.44 -55.53 20.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.788 -0.706 . . . . 0.0 109.466 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -46.19 57.44 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.14 0.495 . . . . 0.0 110.736 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -58.79 -46.47 87.49 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -24.58 60.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 20.2 mtt180 -89.18 8.88 27.88 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.74 3.68 90.54 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.483 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 19.3 m-85 -78.43 -175.99 4.53 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.37 -1.332 . . . . 0.0 110.02 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -101.92 -22.34 14.34 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.487 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 162.52 159.55 10.42 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.16 -171.85 20.22 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -170.13 177.83 4.09 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.604 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -81.84 154.03 26.1 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.86 -99.63 0.01 OUTLIER Glycine 0 N--CA 1.493 2.443 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.85 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -164.7 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -66.03 129.42 39.72 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.62 -1.632 . . . . 0.0 110.129 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.91 28.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.376 -1.738 . . . . 0.0 113.443 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.725 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.9 m120 49.21 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.108 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 m -107.55 -39.46 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 121.614 -0.679 . . . . 0.0 112.347 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 6' ' ' SER . 1.4 m120 -151.23 152.56 33.44 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.849 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.7 117.59 34.39 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.484 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 41.9 m95 -108.11 145.23 34.39 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.855 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -95.05 170.22 9.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -104.37 36.29 2.44 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.118 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.506 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.994 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -125.72 144.85 50.44 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.701 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.07 120.25 34.06 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.909 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.74 -4.8 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.999 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.505 ' HA2' ' OD1' ' A' ' 13' ' ' ASN . . . -178.51 -175.7 45.82 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.6 t -110.8 179.33 4.09 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.987 0.915 . . . . 0.0 110.237 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.597 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 61.4 m -127.29 30.84 5.32 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.22 92.81 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.188 0.518 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -47.43 121.42 3.9 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.223 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.22 -33.87 4.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.34 155.77 37.81 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.88 48.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 122.204 1.002 . . . . 0.0 110.522 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 0.7 OUTLIER -161.66 13.67 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.04 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.439 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 84.2 t80 -72.11 142.86 49.17 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.947 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.9 p -104.86 102.62 12.16 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 119.369 -0.348 . . . . 0.0 111.815 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.08 -30.33 15.57 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -142.96 80.58 1.69 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.39 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 49.4 t -42.81 -56.7 3.1 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.376 0.607 . . . . 0.0 111.875 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -39.1 77.51 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.479 -0.888 . . . . 0.0 109.974 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.26 -53.5 31.0 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 6.3 tp10 -61.76 -47.06 86.89 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 1.9 t -51.08 -48.32 61.67 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.721 0.772 . . . . 0.0 110.475 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 11.8 tptp -59.51 -44.41 93.12 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 21' ' ' GLU . 9.2 ttm180 -59.14 -24.8 63.33 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.0 mtt180 -90.6 11.44 21.99 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.219 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.68 20.34 63.83 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.306 -1.918 . . . . 0.0 108.306 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 12.7 m-30 -87.13 163.31 17.04 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.98 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HZ2' ' CB ' ' A' ' 28' ' ' LYS . 1.4 mtpm? -59.2 -35.04 72.89 Favored 'General case' 0 N--CA 1.501 2.12 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.24 160.54 10.09 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.3 167.22 28.5 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 4.0 p-80 -175.89 170.5 2.78 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 t -85.15 170.05 13.27 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.19 57.55 0.07 OUTLIER Glycine 0 N--CA 1.5 2.921 0 C-N-CA 119.24 -1.457 . . . . 0.0 110.258 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.9 m -141.57 -151.57 0.37 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -92.44 139.8 30.23 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.07 31.87 0.38 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.33 0.394 . . . . 0.0 111.798 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 30.5 m-80 55.94 90.97 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.389 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.0 m -127.27 -24.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 7' ' ' CYS . 30.3 m-80 -128.99 126.89 40.51 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.71 103.91 15.83 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -92.5 155.46 17.81 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.504 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 166.27 17.85 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 30.1 mt-10 -113.45 107.86 16.41 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.429 HG22 ' CG ' ' A' ' 27' ' ' TYR . 21.3 p . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.007 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 16.4 m-20 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -130.81 164.36 25.35 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 64.7 tp -104.18 113.11 26.43 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.7 pp -107.42 -14.36 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.382 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.75 -179.86 40.18 Favored Glycine 0 N--CA 1.5 2.908 0 C-N-CA 118.857 -1.64 . . . . 0.0 109.86 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.16 -176.12 3.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 48.1 t -138.58 33.71 2.25 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.575 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.79 94.42 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.362 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.405 ' CE2' ' CE2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -46.71 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 120.964 0.411 . . . . 0.0 111.18 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 -30.19 0.41 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.56 159.01 20.75 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.791 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -85.51 45.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.246 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -157.97 19.27 0.25 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.047 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' CE2' ' A' ' 9' ' ' TRP . 66.7 t80 -82.4 145.0 30.11 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.332 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -108.42 106.64 16.85 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.789 -0.765 . . . . 0.0 111.216 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.3 m -53.84 -47.94 70.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -123.98 90.6 3.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.8 t -47.2 -59.76 2.94 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.41 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.407 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -63.07 -33.65 75.89 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.541 -0.863 . . . . 0.0 109.556 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.0 41.5 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -62.97 -53.17 58.14 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.841 0.829 . . . . 0.0 109.001 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.46 -51.53 26.55 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.219 1.009 . . . . 0.0 110.389 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -61.6 -39.88 92.79 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.15 -26.36 50.08 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.98 17.92 18.49 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.988 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 9.82 68.44 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.761 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 19.9 m-30 -76.01 -168.23 0.87 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.131 -1.027 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -93.87 -51.41 4.9 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -178.77 179.03 48.88 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -177.67 159.56 25.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 3.6 p-80 -168.67 174.4 6.69 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.6 t -74.66 170.08 16.53 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.68 59.6 0.05 OUTLIER Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.377 -1.392 . . . . 0.0 111.109 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.2 m -148.01 -154.92 0.58 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -92.64 139.78 30.21 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 44.88 28.58 0.37 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.344 0.402 . . . . 0.0 111.337 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 27.3 m-80 57.27 91.38 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.493 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 4.9 m -124.28 -27.04 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -137.3 153.04 50.37 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.523 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.18 117.07 29.48 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 27.5 m95 -101.09 148.9 24.53 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.607 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.494 ' SG ' HG12 ' A' ' 4' ' ' ILE . 3.4 m -114.88 167.75 10.51 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -98.92 31.34 3.02 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.163 0.506 . . . . 0.0 111.563 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.514 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 34.3 p . . . . . 0 N--CA 1.503 2.222 0 CA-C-O 114.662 -2.589 . . . . 0.0 108.686 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.16 145.23 27.72 Favored 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.31 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 20.0 tp -104.99 122.83 46.67 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.886 -1.134 . . . . 0.0 109.882 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.483 ' O ' ' NH2' ' A' ' 25' ' ' ARG . 1.8 pp -122.51 -8.64 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.162 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.56 178.86 45.3 Favored Glycine 0 N--CA 1.502 3.051 0 C-N-CA 118.95 -1.595 . . . . 0.0 110.556 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 2.9 m -97.28 -178.22 4.1 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.701 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 49.9 t -147.39 22.77 1.17 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.502 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -83.97 -18.61 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.193 0.521 . . . . 0.0 112.313 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 61.27 70.69 0.59 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 123.02 1.39 . . . . 0.0 107.412 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.2 -35.11 0.14 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.83 162.77 28.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.3 p -84.2 43.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.381 1.086 . . . . 0.0 111.937 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -156.57 19.61 0.34 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.626 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 90.1 t80 -71.47 142.87 50.2 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.505 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.45 110.93 23.44 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -58.19 -41.36 83.77 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -128.72 92.09 3.35 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -44.49 -59.55 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.719 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.565 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -65.88 -31.96 73.2 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.598 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.24 -57.04 21.16 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.574 ' CG ' HH21 ' A' ' 25' ' ' ARG . 14.6 tp10 -60.02 -49.31 78.16 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' TYR . 4.2 t -48.84 -49.79 37.58 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.755 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 54.7 mtpt -57.94 -46.82 84.47 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -25.95 59.76 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.574 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.0 mmt180 -88.31 8.52 27.04 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.919 -0.488 . . . . 0.0 110.036 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.52 71.69 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.733 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.5 m-30 -93.62 176.18 6.46 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -74.42 -64.35 1.05 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.908 0.861 . . . . 0.0 109.359 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.565 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.82 -173.57 41.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -163.09 -166.5 22.01 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.527 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' CE1' ' OE2' ' A' ' 43' ' ' GLU . 16.2 p-80 -166.02 178.19 6.56 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 44.2 t -80.84 154.38 27.14 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.85 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.554 -1.308 . . . . 0.0 113.824 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -165.53 -70.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 119.386 -0.925 . . . . 0.0 112.481 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -76.93 132.91 39.32 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.022 -1.471 . . . . 0.0 110.55 -179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 39.5 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.631 -1.622 . . . . 0.0 113.701 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 15.2 m-20 47.08 90.73 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.022 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -110.79 -44.82 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 120.987 -1.07 . . . . 0.0 113.824 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 75.8 m-20 -135.25 141.5 45.76 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.11 112.9 24.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 63.0 m95 -101.64 146.54 27.57 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.155 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.455 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 21.9 m -104.82 162.85 12.96 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' OE2' ' CE1' ' A' ' 31' ' ' HIS . 3.7 mm-40 -101.26 32.84 3.1 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.08 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.733 HG21 ' CG ' ' A' ' 27' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 115.888 -2.006 . . . . 0.0 111.805 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 27' ' ' TYR . 4.0 tppp? -120.58 143.22 48.74 Favored 'General case' 0 N--CA 1.51 2.554 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.077 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.2 tp -95.85 107.45 19.7 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.58 -18.15 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.514 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.57 -179.54 39.88 Favored Glycine 0 N--CA 1.503 3.126 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.432 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . 9.8 t -101.93 173.18 6.51 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 12.8 t -128.12 29.61 5.35 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.286 1.041 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.01 89.0 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.831 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.12 92.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 120.651 0.262 . . . . 0.0 110.68 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.85 -26.55 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.13 160.88 20.8 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.014 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.3 t -83.71 47.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.785 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 6' ' ' SER . 37.0 p30 -166.44 24.47 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.055 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -75.51 143.48 42.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.148 -1.421 . . . . 0.0 109.062 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.31 98.7 7.68 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.853 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.4 t -60.14 -51.51 69.28 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.574 -0.85 . . . . 0.0 109.321 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -101.73 76.47 1.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 123.031 1.396 . . . . 0.0 107.742 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.0 t -49.04 -56.76 8.02 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.079 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -72.24 -42.73 65.33 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.269 -179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.79 -46.58 48.3 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.02 -51.23 49.45 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.823 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.7 t -45.21 -51.75 10.27 Favored 'General case' 0 N--CA 1.508 2.47 0 CA-C-O 122.298 1.047 . . . . 0.0 109.549 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -49.87 75.11 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -56.88 -24.55 52.69 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.389 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -88.69 8.35 29.1 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.429 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.41 8.69 87.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.487 ' OH ' ' NZ ' ' A' ' 2' ' ' LYS . 20.5 m-30 -91.55 178.14 6.02 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.695 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 30.2 mttp -71.26 -65.03 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 122.11 0.957 . . . . 0.0 109.335 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 179.67 169.1 39.53 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -146.83 -163.89 10.74 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -175.21 176.85 1.99 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 52.5 t -82.11 157.46 24.07 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.875 -1.155 . . . . 0.0 112.939 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.1 m -166.74 -69.97 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 118.612 1.206 . . . . 0.0 112.374 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -70.23 128.52 36.54 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 117.739 -1.584 . . . . 0.0 110.466 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 38.64 24.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 113.184 -1.825 . . . . 0.0 113.666 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.0 m-20 51.15 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.644 0.656 . . . . 0.0 111.077 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.83 -39.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -132.49 146.61 52.06 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.72 110.9 22.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -101.01 150.79 22.53 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.873 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 3.1 m -115.42 164.97 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -77.7 -61.43 1.99 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.195 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 54.0 p . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.751 ' HD2' HG23 ' A' ' 44' ' ' THR . 12.7 mttt -115.25 122.73 46.87 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.194 0.452 . . . . 0.0 110.28 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 7.5 tt -78.3 111.88 14.73 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.03 -8.97 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.058 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.68 -178.15 44.34 Favored Glycine 0 N--CA 1.501 2.992 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -94.12 -174.12 3.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 122.068 -0.666 . . . . 0.0 109.276 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.1 t -146.75 18.5 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 38' ' ' VAL . 11.3 t -84.65 -117.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.398 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -174.99 88.05 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.004 -1.06 . . . . 0.0 110.328 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.89 -17.55 3.42 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.417 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.35 155.09 28.59 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.309 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -84.75 44.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.973 0.892 . . . . 0.0 111.042 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -155.24 11.26 0.33 Allowed 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.378 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -75.96 144.61 40.89 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 119.044 0.838 . . . . 0.0 109.048 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.6 p -108.12 107.66 18.41 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.355 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -58.93 -37.61 77.08 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -127.35 89.87 3.04 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 3.7 t -47.79 -54.47 12.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.603 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.53 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -67.56 -33.4 74.96 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.13 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.16 -53.77 38.35 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 107.274 -2.33 . . . . 0.0 107.274 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.96 -50.73 67.47 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -48.54 -51.72 26.19 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.658 0.742 . . . . 0.0 109.79 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -61.25 -40.77 95.31 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.3 -25.05 63.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 9.0 mtt180 -92.72 13.0 21.45 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.737 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.45 11.66 76.57 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.851 ' CG ' HG21 ' A' ' 44' ' ' THR . 10.2 m-30 -83.06 -171.64 3.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.309 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' H ' ' HG2' ' A' ' 28' ' ' LYS . 9.3 ptmt -97.72 -32.38 11.77 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.213 0.53 . . . . 0.0 111.307 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.53 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 164.45 167.2 24.62 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -161.36 -177.6 34.58 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.557 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.5 p-80 -178.84 174.22 1.15 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 30.6 t -75.99 165.77 24.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.27 70.54 0.05 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.266 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.2 m -156.49 -152.86 0.39 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.19 136.08 33.22 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.17 33.33 0.38 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.673 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.66 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 18.5 m-20 58.38 89.0 0.06 Allowed 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.816 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 8' ' ' VAL . 7.4 m -126.9 -27.47 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.611 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -133.28 142.4 48.47 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.649 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.4 OUTLIER -108.41 118.72 37.51 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.44 ' CZ3' ' HB2' ' A' ' 3' ' ' LEU . 14.9 m95 -105.32 157.31 17.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.387 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' HG22 ' A' ' 44' ' ' THR . 1.9 m -113.48 168.35 9.83 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 28' ' ' LYS . 0.9 OUTLIER -86.13 -30.8 22.24 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.085 0.469 . . . . 0.0 111.306 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.851 HG21 ' CG ' ' A' ' 27' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.523 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -116.45 116.02 26.89 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.894 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 63.3 tp -76.48 114.88 15.7 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -105.55 -13.49 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.616 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.95 173.2 45.52 Favored Glycine 0 N--CA 1.502 3.097 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.41 177.43 5.95 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.367 -1.078 . . . . 0.0 109.008 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 9.1 t -133.26 38.35 3.32 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 118.648 -1.221 . . . . 0.0 109.658 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.58 96.93 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.342 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.09 104.56 0.06 Allowed 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.034 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.0 -30.49 0.9 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.59 159.78 18.44 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.83 45.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.645 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -162.8 21.16 0.09 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.645 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -72.12 146.31 47.58 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.738 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.85 112.03 24.46 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.5 t -65.94 -49.61 67.35 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -117.02 89.61 3.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 123.047 1.403 . . . . 0.0 107.785 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 1.7 t -46.96 -63.11 1.12 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.22 -1.355 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -28.05 64.6 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.794 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.72 -52.56 51.7 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 107.749 -2.14 . . . . 0.0 107.749 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -64.12 -51.3 64.61 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 3.8 t -47.46 -49.75 24.72 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-O 122.562 1.172 . . . . 0.0 109.278 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -58.01 -48.22 80.68 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -23.98 51.18 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -90.47 11.1 22.72 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.455 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.55 16.7 72.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.714 ' CG ' HG22 ' A' ' 44' ' ' THR . 16.3 m-30 -89.04 158.82 17.86 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.741 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -67.25 -29.03 68.54 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.977 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.64 171.58 19.64 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -152.58 -160.24 9.49 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.468 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 11.4 p-80 -174.32 174.9 2.73 Favored 'General case' 0 N--CA 1.503 2.192 0 C-N-CA 119.939 -0.705 . . . . 0.0 109.158 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.2 t -84.87 159.5 20.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' ASN . . . -55.84 -99.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.279 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.9 m -163.88 -70.26 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.31 -0.956 . . . . 0.0 112.364 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -74.35 129.65 38.19 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 117.618 -1.633 . . . . 0.0 110.354 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 37.37 27.99 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.341 -1.754 . . . . 0.0 113.137 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.691 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.2 m-80 56.09 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.577 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.02 -41.15 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 C-N-CA 119.351 -0.94 . . . . 0.0 112.558 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 76.3 m-20 -146.9 146.88 30.31 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.72 110.74 23.13 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -101.84 144.91 29.91 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.571 -0.851 . . . . 0.0 111.562 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.427 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 8.5 m -111.06 164.34 12.93 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.97 -46.54 8.8 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.714 HG22 ' CG ' ' A' ' 27' ' ' TYR . 82.5 p . . . . . 0 N--CA 1.509 2.522 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -95.34 148.52 22.35 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.787 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 5' ' ' GLY . 53.7 tp -107.33 110.27 22.23 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.715 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.94 -21.04 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.287 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.443 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -161.27 174.06 37.78 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.514 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 36.7 t -89.13 -171.33 3.22 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 42.4 t -137.99 28.02 2.63 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.337 0.589 . . . . 0.0 109.596 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 t -113.25 90.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.982 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.463 ' CD1' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -45.96 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 122.442 0.297 . . . . 0.0 110.411 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.42 -30.81 0.86 Allowed Glycine 0 N--CA 1.502 3.056 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.27 160.77 29.96 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.53 44.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.19 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 6' ' ' SER . 0.1 OUTLIER -165.92 24.1 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.409 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' CE2' ' CD1' ' A' ' 9' ' ' TRP . 83.3 t80 -85.16 143.12 29.0 Favored 'General case' 0 N--CA 1.502 2.163 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.141 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 p -100.56 102.64 13.85 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.429 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.2 t -52.14 -38.85 58.86 Favored 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -126.92 92.55 3.56 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 31' ' ' HIS . 11.6 t -49.78 -58.98 4.27 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.446 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -71.56 -26.43 62.63 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 118.696 -1.202 . . . . 0.0 108.968 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.24 -51.57 58.03 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.69 -48.59 66.14 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.711 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -51.27 -50.09 59.94 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.024 0.916 . . . . 0.0 109.527 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 23' ' ' LYS . 48.6 tptt -59.01 -43.54 91.57 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -26.57 63.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.92 7.58 26.74 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.31 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.62 16.87 68.29 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -89.13 167.08 13.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 117.779 0.79 . . . . 0.0 108.987 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.577 ' HZ3' ' C ' ' A' ' 44' ' ' THR . 47.1 mttp -60.63 -59.79 4.83 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.779 0.799 . . . . 0.0 110.09 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 43' ' ' GLU . . . -178.88 -177.23 47.34 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -169.49 170.1 42.44 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.592 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 1.8 p-80 -175.49 175.99 2.03 Favored 'General case' 0 N--CA 1.507 2.379 0 CA-C-O 121.312 0.577 . . . . 0.0 109.539 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 13.7 t -82.81 168.64 16.95 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.678 -1.209 . . . . 0.0 107.89 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.46 55.6 0.06 OUTLIER Glycine 0 N--CA 1.498 2.81 0 C-N-CA 118.668 -1.73 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.1 m -146.44 -153.23 0.47 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -93.14 139.79 30.21 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 45.1 28.87 0.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 123.342 0.401 . . . . 0.0 111.77 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 9.1 m120 57.56 93.42 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.505 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.62 -27.02 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -137.48 141.8 41.53 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.001 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -100.91 104.0 15.19 Favored 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 1' ' ' ASP . 59.9 m95 -90.6 144.47 25.73 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.923 -179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 8.8 m -111.66 164.21 13.27 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 28' ' ' LYS . 1.5 mm-40 -83.74 -52.36 6.48 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.671 -1.211 . . . . 0.0 111.906 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.577 ' C ' ' HZ3' ' A' ' 28' ' ' LYS . 46.7 p . . . . . 0 N--CA 1.508 2.458 0 CA-C-O 124.93 2.3 . . . . 0.0 115.356 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 1.1 m-20 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 44' ' ' THR . 22.9 tptt -110.05 124.54 51.65 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 123.665 0.603 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -80.85 117.84 21.85 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.29 1.49 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.239 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 -177.93 45.32 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 10.4 t -102.63 -164.3 1.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 14.6 t -151.26 31.62 0.6 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.752 0.787 . . . . 0.0 109.332 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.43 95.32 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.113 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -44.21 94.84 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.192 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.72 -24.7 1.33 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.5 156.13 23.01 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.292 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.1 p -83.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-O 121.701 0.763 . . . . 0.0 111.906 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -160.32 19.54 0.15 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.459 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 67.8 t80 -76.64 146.4 38.2 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.593 -0.843 . . . . 0.0 108.978 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 p -106.57 116.81 32.58 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -55.94 -37.46 69.02 Favored 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -135.61 93.46 2.96 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 122.461 1.124 . . . . 0.0 108.532 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 3.5 t -47.32 -58.99 3.51 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.691 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.421 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.02 -38.25 72.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.76 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -53.64 -52.29 42.88 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 21.9 tp10 -61.48 -51.96 66.48 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.5 t -45.34 -52.54 9.72 Favored 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.197 0.998 . . . . 0.0 110.02 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -58.2 -47.32 83.83 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 ttp85 -56.65 -26.74 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -89.3 10.09 23.58 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.383 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.36 13.32 77.1 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.571 ' CG ' HG22 ' A' ' 44' ' ' THR . 14.9 m-30 -90.27 169.18 11.33 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.209 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.09 -65.17 0.72 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.499 0.666 . . . . 0.0 109.581 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -175.57 160.23 28.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -142.12 -165.95 10.72 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.689 -1.243 . . . . 0.0 110.593 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.476 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 6.2 p-80 -177.28 174.88 1.56 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 43.1 t -77.0 154.41 33.53 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.14 -93.57 0.01 OUTLIER Glycine 0 N--CA 1.486 2.019 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.093 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.3 -69.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.581 -0.848 . . . . 0.0 113.03 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -61.07 124.27 20.04 Favored 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 117.046 -1.862 . . . . 0.0 110.809 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.28 28.82 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.091 -1.868 . . . . 0.0 113.252 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.686 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.6 m-80 50.48 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.335 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.78 -45.62 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.098 -1.001 . . . . 0.0 112.444 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 72.4 m-20 -130.19 161.24 31.58 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.42 -0.912 . . . . 0.0 112.488 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 122.01 46.57 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -115.71 146.57 41.77 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.451 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 1' ' ' ASP . 4.4 m -111.95 166.5 11.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.44 -62.34 1.69 Allowed 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.713 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 27' ' ' TYR . 75.4 p . . . . . 0 N--CA 1.51 2.531 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.766 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -114.0 124.49 52.26 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.391 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.488 HD13 ' CH2' ' A' ' 41' ' ' TRP . 13.5 tp -84.08 112.4 20.18 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.61 12.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.967 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.81 176.88 41.73 Favored Glycine 0 N--CA 1.497 2.749 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 t -111.49 -179.66 3.77 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HB2' ' C ' ' A' ' 37' ' ' ASN . 69.3 m -128.74 28.67 5.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.89 88.84 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.985 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -44.27 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.7 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.42 -29.84 2.25 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.94 157.95 34.13 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -85.24 46.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -155.77 12.94 0.33 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.802 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -74.93 143.57 43.66 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 119.874 1.216 . . . . 0.0 109.206 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.05 100.82 8.9 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.9 t -53.09 -45.83 68.38 Favored 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -124.73 86.38 2.55 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.638 1.685 . . . . 0.0 108.836 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.7 t -50.28 -52.16 38.78 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.046 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -68.67 -31.87 71.29 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.31 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.82 -54.71 35.24 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 11.6 tp10 -63.55 -50.46 69.42 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 4.9 t -47.47 -52.27 17.72 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.398 1.094 . . . . 0.0 110.338 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -60.24 -42.82 96.09 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 21' ' ' GLU . 11.9 ttp85 -56.88 -25.75 57.42 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HG3' ' HA ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -93.97 14.71 18.82 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.509 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.93 9.58 75.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 44' ' ' THR . 13.9 m-30 -85.85 170.97 11.9 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.852 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -69.82 -67.97 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.52 0.676 . . . . 0.0 110.357 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -160.14 176.53 36.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -170.77 152.75 19.39 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 1.2 p-80 -164.63 173.19 12.22 Favored 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 6.1 t -72.13 169.47 16.0 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.365 -1.334 . . . . 0.0 107.848 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.52 56.04 0.05 OUTLIER Glycine 0 N--CA 1.5 2.949 0 C-N-CA 119.393 -1.384 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.2 m -140.63 -149.22 0.27 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -93.32 136.96 33.09 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.32 34.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 123.324 0.39 . . . . 0.0 111.677 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.572 ' C ' ' HB2' ' A' ' 7' ' ' CYS . 4.4 m120 56.93 86.57 0.07 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.923 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.484 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 5.5 m -123.81 -26.34 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.431 HD22 ' CD1' ' A' ' 3' ' ' LEU . 2.6 m120 -135.42 150.49 49.89 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -115.39 120.99 41.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.488 ' CH2' HD13 ' A' ' 3' ' ' LEU . 23.4 m95 -110.88 143.87 40.8 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.807 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 4.6 m -104.16 163.41 12.42 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -102.72 43.62 1.06 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.528 HG22 ' CG ' ' A' ' 27' ' ' TYR . 16.7 p . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.085 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.696 -0.113 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -130.22 150.44 51.47 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.946 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 7.9 tp -94.08 114.24 26.35 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.534 -0.729 . . . . 0.0 110.07 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 5' ' ' GLY . 2.6 pp -101.65 -19.48 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.878 -1.129 . . . . 0.0 109.452 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.494 ' N ' HD12 ' A' ' 4' ' ' ILE . . . -164.96 179.34 39.63 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.13 -179.29 3.91 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.618 -0.931 . . . . 0.0 108.635 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.717 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 7.7 t -133.16 36.99 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.827 -1.149 . . . . 0.0 110.101 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.27 97.62 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.989 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -47.46 95.19 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.063 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.26 -28.17 0.63 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.11 159.82 21.04 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.373 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.57 48.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.179 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.432 ' OD1' ' HA2' ' A' ' 5' ' ' GLY . 1.3 t-20 -164.04 18.76 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.605 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -74.17 142.69 45.45 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.599 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.32 100.12 7.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.7 t -58.23 -45.55 87.51 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 122.237 1.018 . . . . 0.0 109.684 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -110.11 78.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.84 -59.33 3.4 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.266 0.555 . . . . 0.0 112.143 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -62.8 -37.48 86.87 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.25 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.3 -50.66 62.92 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 9.3 tp10 -62.22 -52.05 65.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 29' ' ' GLY . 5.1 t -48.16 -50.75 27.78 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 122.354 1.073 . . . . 0.0 109.605 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HG3' ' ND2' ' A' ' 19' ' ' ASN . 73.8 mttt -58.65 -41.9 87.13 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -25.28 61.86 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.82 15.86 15.55 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.957 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.49 17.27 61.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CG ' HG21 ' A' ' 44' ' ' THR . 11.4 m-30 -85.64 176.91 7.91 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.487 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -72.31 -69.3 0.41 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 122.062 0.934 . . . . 0.0 110.048 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.541 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -159.33 175.27 36.26 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -157.38 157.89 28.49 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' ND1' ' N ' ' A' ' 31' ' ' HIS . 12.1 p-80 -150.47 176.84 10.57 Favored 'General case' 0 N--CA 1.506 2.373 0 CA-C-N 115.041 -0.579 . . . . 0.0 109.776 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 50.5 t -84.63 156.38 21.58 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.31 -95.57 0.01 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.863 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.6 m -165.6 -73.37 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.038 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -76.72 133.87 39.37 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 117.552 -1.659 . . . . 0.0 111.391 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 40.58 23.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.478 -1.692 . . . . 0.0 113.602 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 1.2 m-80 50.11 91.0 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.254 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.6 m -110.56 -40.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.195 -0.94 . . . . 0.0 112.027 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 8.4 m120 -139.26 156.02 47.35 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 120.13 41.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -111.37 146.28 37.4 Favored 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.342 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 3.9 m -104.83 160.02 15.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -91.38 26.31 2.29 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.476 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.889 -0.507 . . . . 0.0 110.936 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -109.14 134.39 51.78 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.713 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 5.0 tp -88.27 109.87 20.29 Favored 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -98.05 -9.45 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 C-N-CA 118.236 -1.386 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.58 179.68 43.95 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 36.5 t -105.42 175.93 5.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.985 -0.715 . . . . 0.0 109.675 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 37' ' ' ASN . 96.6 m -124.33 26.67 7.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.17 89.73 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.576 0.703 . . . . 0.0 110.447 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -43.07 104.22 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.104 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.18 -29.89 3.42 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.93 158.69 36.03 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.39 47.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.201 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -164.71 16.4 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.024 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -73.66 145.36 45.36 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.441 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.18 96.14 5.1 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -55.52 -46.16 77.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.046 -1.062 . . . . 0.0 109.966 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -107.71 74.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.5 t -47.74 -53.75 14.27 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -70.69 -36.24 73.18 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.44 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.69 -54.96 32.51 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' OE1' ' NH2' ' A' ' 24' ' ' ARG . 13.2 tp10 -58.32 -47.14 84.65 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER -51.35 -50.79 58.8 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.604 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -57.49 -44.17 84.73 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -58.93 -24.27 62.28 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.346 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 13.57 18.92 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.651 -0.819 . . . . 0.0 109.872 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.21 16.52 66.96 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.5 m-30 -88.07 163.05 16.44 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.411 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 43' ' ' GLU . 44.5 mttt -60.25 -66.85 0.46 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 123.354 1.55 . . . . 0.0 108.685 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.496 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . -173.54 162.16 33.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -144.95 -168.66 12.93 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -176.46 175.67 1.73 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.6 t -81.96 156.56 24.65 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -99.05 0.01 OUTLIER Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.949 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -169.09 -72.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 118.79 1.295 . . . . 0.0 111.955 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.24 126.19 26.47 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.511 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 35.92 26.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 113.414 -1.721 . . . . 0.0 113.59 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 1.1 m120 44.22 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 CA-C-N 118.32 0.509 . . . . 0.0 111.16 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.34 -35.08 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.506 -0.746 . . . . 0.0 112.044 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 81.2 m-20 -141.01 161.19 38.42 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.342 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 122.39 45.22 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -104.5 152.32 22.52 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.066 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 4.5 t -130.89 172.67 11.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 123.481 0.488 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.52 ' C ' ' HD2' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -114.99 121.77 44.16 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.91 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.416 HG22 ' CG ' ' A' ' 27' ' ' TYR . 32.5 p . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 115.783 -2.056 . . . . 0.0 108.764 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -124.64 122.95 38.96 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.147 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 40' ' ' CYS . 10.9 tp -82.33 121.17 26.35 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.205 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG21 ' SG ' ' A' ' 22' ' ' CYS . 1.7 pp -111.04 -14.88 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 C-N-CA 118.818 -1.153 . . . . 0.0 110.19 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.15 -173.66 39.01 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.155 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.0 t -102.94 176.99 4.97 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.659 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 35.6 t -137.62 19.94 2.89 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.83 -22.53 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.189 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 63.97 93.38 0.06 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 122.269 1.033 . . . . 0.0 108.438 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -33.13 2.36 Favored Glycine 0 N--CA 1.502 3.094 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.38 161.11 25.92 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -83.8 39.63 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-O 122.278 1.037 . . . . 0.0 111.641 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -157.1 19.45 0.3 Allowed 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.572 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' A' ' 7' ' ' CYS . 64.1 t80 -77.8 143.8 37.61 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.785 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -96.19 107.0 19.27 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.022 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.9 m -55.68 -36.05 66.68 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -131.94 87.51 2.45 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 31' ' ' HIS . 7.8 t -46.6 -62.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.246 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.536 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.5 OUTLIER -67.77 -43.45 79.76 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.636 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.12 -50.61 33.23 Favored Glycine 0 N--CA 1.505 3.269 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.3 tp10 -63.4 -59.72 4.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.532 -0.467 . . . . 0.0 109.936 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -47.54 -44.54 25.95 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 122.004 0.907 . . . . 0.0 110.891 -179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -61.66 -45.57 93.47 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -21.45 59.6 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 1.1 mtt-85 -87.69 6.31 35.47 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.533 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.89 4.08 87.42 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.688 ' CG ' HG21 ' A' ' 44' ' ' THR . 17.8 m-30 -87.17 147.89 25.41 Favored 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.754 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -54.02 -32.7 55.11 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 149.09 165.85 12.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' CA ' ' HA ' ' A' ' 42' ' ' CYS . . . -149.85 -160.76 9.42 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.415 ' C ' ' SG ' ' A' ' 18' ' ' CYS . 10.8 p-80 -173.32 174.85 3.23 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.466 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 39.1 t -77.68 154.35 32.22 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.27 -95.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.233 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.214 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -166.36 -74.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.094 0.947 . . . . 0.0 113.145 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -76.12 134.19 40.06 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.202 -1.399 . . . . 0.0 111.054 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 42.98 21.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.718 -1.583 . . . . 0.0 113.757 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.713 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 2.7 m-20 41.76 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 CA-C-N 118.943 0.792 . . . . 0.0 111.789 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 m -111.18 -36.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.329 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -144.17 158.08 43.93 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.763 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -108.31 123.17 48.4 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -114.32 146.45 40.48 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.504 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HA ' ' CA ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -108.54 170.94 7.71 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -90.96 -26.08 19.43 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.968 0.792 . . . . 0.0 112.19 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.688 HG21 ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 113.721 -3.037 . . . . 0.0 111.1 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 121.332 0.587 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -81.21 156.19 25.77 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.293 -1.363 . . . . 0.0 110.284 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 5' ' ' GLY . 50.2 tp -110.79 115.26 29.24 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.86 -0.525 . . . . 0.0 110.321 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.488 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -103.3 -22.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.724 -0.791 . . . . 0.0 110.285 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 3' ' ' LEU . . . -163.79 177.82 39.48 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 t -101.84 172.86 6.69 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.779 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 8.1 t -128.27 35.05 4.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.22 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.7 t -121.23 94.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.617 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -47.31 103.64 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 121.181 0.515 . . . . 0.0 111.084 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.04 -28.72 0.64 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.66 158.91 16.67 Favored 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.8 t -85.2 49.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.428 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.06 19.86 0.12 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -74.17 141.65 45.51 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.315 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 HG21 ' CD1' ' A' ' 4' ' ' ILE . 7.4 p -105.49 102.23 11.71 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 119.194 -0.432 . . . . 0.0 111.887 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -38.4 71.9 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -121.31 78.77 1.45 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 49.2 t -47.42 -62.24 1.53 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.154 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.559 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -71.18 -26.17 62.85 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 118.101 -1.44 . . . . 0.0 109.593 -179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.63 -55.07 32.55 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 8.6 tp10 -61.34 -48.09 82.9 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.9 t -49.33 -51.69 32.68 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.912 0.863 . . . . 0.0 110.125 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -59.7 -40.73 88.87 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.9 -26.31 65.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 11.8 mtt-85 -92.58 14.39 17.04 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.874 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.4 18.36 63.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' CG ' HG22 ' A' ' 44' ' ' THR . 12.3 m-30 -84.06 166.43 17.72 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 109.766 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 43' ' ' GLU . 14.4 mtpt -64.95 -28.34 69.46 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.88 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.559 ' HA2' ' ND2' ' A' ' 19' ' ' ASN . . . 140.03 163.49 9.53 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.29 -160.86 8.47 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.44 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -176.59 176.4 1.57 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 41.8 t -86.45 157.47 19.8 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.13 -98.48 0.01 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.906 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -162.74 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.397 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -74.97 133.36 41.72 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 117.986 -1.486 . . . . 0.0 110.069 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 41.06 24.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 113.585 -1.643 . . . . 0.0 113.354 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.679 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.6 m120 56.25 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.494 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.38 -38.68 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 78.6 m-20 -152.18 148.17 27.28 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.9 t -90.19 99.74 12.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -86.28 151.01 23.95 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.948 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.488 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.4 m -128.31 169.67 13.95 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 123.023 0.529 . . . . 0.0 110.604 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' O ' ' HD3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -119.63 108.95 15.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.839 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.402 HG22 ' CG ' ' A' ' 27' ' ' TYR . 7.9 p . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 116.303 -1.808 . . . . 0.0 107.589 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -112.57 137.84 50.23 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 33.6 tp -88.51 122.45 32.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 122.041 -0.412 . . . . 0.0 110.074 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' A' ' 42' ' ' CYS . 2.5 pp -116.96 -13.4 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.608 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.61 -179.65 40.49 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -97.28 -166.66 1.42 Allowed 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 37' ' ' ASN . 43.9 t -149.45 32.67 0.72 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.592 0.711 . . . . 0.0 109.14 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -116.72 93.64 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -45.37 97.47 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.332 0.587 . . . . 0.0 110.94 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.49 -24.64 1.68 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.64 158.3 21.93 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.615 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.04 47.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.644 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.69 18.84 0.11 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.507 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -81.15 138.86 35.85 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 117.647 -1.621 . . . . 0.0 109.07 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 p -97.37 100.07 11.51 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.304 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.6 t -51.02 -38.81 53.65 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -129.63 85.62 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.875 1.321 . . . . 0.0 107.763 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' SG ' ' CA ' ' A' ' 31' ' ' HIS . 5.2 t -48.78 -60.57 2.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.478 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.0 -30.45 71.61 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.4 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.74 -59.13 11.4 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' ARG . 17.1 tp10 -57.37 -49.29 76.65 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.7 t -50.37 -49.66 53.66 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -58.8 -43.83 90.6 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -26.56 62.94 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -93.13 14.98 16.34 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.644 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.48 20.01 60.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -86.07 169.16 13.41 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.8 mttp -68.74 -42.47 77.54 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.192 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.74 171.98 36.6 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -162.42 159.28 31.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.527 ' CA ' ' SG ' ' A' ' 18' ' ' CYS . 3.3 p-80 -172.11 172.89 4.48 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 37' ' ' ASN . 12.0 t -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.11 61.28 0.04 OUTLIER Glycine 0 N--CA 1.504 3.193 0 C-N-CA 119.404 -1.379 . . . . 0.0 111.888 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.407 ' CB ' HG12 ' A' ' 38' ' ' VAL . 61.5 m -150.18 -151.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -91.51 137.48 32.33 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 43.62 30.14 0.33 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.579 0.549 . . . . 0.0 111.645 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.697 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 5.2 m-80 59.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' C ' ' HB3' ' A' ' 7' ' ' CYS . 0.9 OUTLIER -125.69 -30.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 C-N-CA 119.931 -0.708 . . . . 0.0 112.642 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.05 154.26 48.18 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.785 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 117.3 32.6 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.368 1.08 . . . . 0.0 108.111 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -98.53 145.2 27.04 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.151 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' HG12 ' A' ' 4' ' ' ILE . 1.2 m -115.36 171.58 7.62 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.118 0.485 . . . . 0.0 109.886 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.265 31.1 mt-10 -113.49 118.02 33.32 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.12 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.284 179.982 . . . . . . . . 0 0 . 1 stop_ save_